The present invention relates to indwelling catheter devices, and more specifically, indwelling catheter devices that minimize, prevent, disrupt, and/or treat catheter occlusion.
There are a number of implantable medical devices, such as indwelling catheters, that are used for the repeated and prolonged access to a patient's vascular system, urinary system, or other bodily conduits. Such devices include peripherally-inserted central catheters (“PICC's”), central venous catheters (“CVC's”), dialysis catheters, implantable ports, midline infusion catheters, and drainage catheters. These devices are typically implanted into a patient for an extended period of time to allow for multiple treatments, such as the delivery of therapeutic agents or dialysis treatments. Use of such devices eliminates the need for multiple placements of single-use devices, thus reducing the risk of infection and placement complications, and reducing the overall cost of patient care. Examples of such implantable medical devices include Vaxcel® PICC's and ports, Xcela® PICC's and ports, Vaxcel® Plus Chronic Dialysis catheters, and the Exodus™ drainage catheter (all from Navilyst Medical, Inc., Marlborough, Mass.).
Like any implantable device placed into the bloodstream, PICC's, ports, and other similar indwelling devices are susceptible to occlusion due to factors relating to thrombosis, encrustation, and the like. Catheter occlusion remains one of the most common noninfectious complications of long-term indwelling devices. Such occlusions can result in catheter malfunction, infection, and/or major vessel thrombosis. Thrombotic causes for catheter obstruction include intraluminal thrombus, extraluminal fibrin sleeve, mural thrombus, or major vessel occlusion and present as either complete or partial occlusion. For example, venous catheters may become encased with a fibrin material shortly after placement within a patient. This fibrin sheath is believed to be comprised of fibrin, platelets, and/or a fibrous collagen substance, and can lead to subsequent catheter occlusion.
In other types of indwelling catheters, such as those that are inserted into the urinary system, catheter occlusion may result from infection of the urine by a urease producing bacteria. Such infection may lead to the formation of a thickening biofilm that results in catheter occlusion. Occlusion may also result from the crystallization of salts from bodily fluids onto the catheter. It is estimated that recurrent blockage of urinary catheters occurs in as many as 50% of long-term catheterized patients.
Current techniques used to minimize, prevent, or treat catheter occlusion include flushing the catheter with fluids, such as heparinized saline to prevent thrombus formation, or citric acid to dissolve encrustation. It would be advantageous, however, to provide catheters that include means to minimize, prevent, disrupt, and/or treat occlusion.
In one aspect, the present invention comprises embodiments of indwelling catheters for inserting into a patient. The catheters comprise a proximal section, a distal end, and a tubular sidewall extending between the proximal and distal ends and defining a lumen for the passage of fluid therethrough. The catheters include at least one cut in the sidewall that extends to the catheter distal end and separates the sidewall into sidewall portions. When the distal end is subjected to a force greater than a threshold force, the sidewall portions move relative to each other to thereby minimize, prevent, disrupt, and/or treat catheter occlusion.
In another aspect, the present invention comprises a method of treating a patient using the catheters of the present invention.
In yet another aspect, the present invention comprises a kit that includes one or more catheters of the present invention.
a and 1b are perspective and end views, respectively, of a catheter according to an embodiment of the present invention that includes two parallel cuts.
a and 2b are side and cross-sectional views, respectively, showing a distal section of the embodiment of
a and 3b are side views, and
a and 4b are side views of a distal section of a catheter according to an embodiment of the present invention that includes relief cuts.
The present invention provides indwelling catheters that may reside in the vasculature or other bodily lumens of patients for prolonged periods of time. As used herein, the term “indwelling catheter” is intended to include any flexible tube that is placed and left in the body over an extended time period. The catheters of the present invention include a unique design that minimizes, prevents, disrupts, and/or treats occlusion due to thrombus formation, encrustation, or the like.
A catheter according to an embodiment of the present invention is shown in side and cross-sectional views in
The catheter 100 illustrated in
The catheter 100 includes at least one cut 150 in the tubular sidewall 130 extending from the distal end 120, the length of the cut(s) 150 defining a distal section 160 of the catheter 100. As used herein, the term “cut” is not limited to a discontinuity created by a particular method of manufacture, but rather is intended to be broad enough to include any gap, break, cut, discontinuity, opening, or the like created in the sidewall 130 by any suitable technique. In an exemplary embodiment, the length of the at least one cut 150, and therefore the length of the distal section 160, is within the range of about 1 mm to about 20 mm, and preferably about 1 mm to about 5 mm. The embodiment shown in
In all embodiments of the invention, the at least one cut 150 extends through to the distal end 120 and separates the sidewall 130 into sidewall portions that move relative to each other due to separation forces, such as internal or external forces, that are greater than a threshold force. An example of such an internal force can result from the passage of fluid through the lumen 140; and an example of such an external force can result from the patient's anatomy, such as a surrounding bodily lumen or tissue such as cyclic forces applied by the superior vena cava.
In the embodiment shown in
In another embodiment of the invention as shown in
Although the embodiments shown in
In the embodiment shown in
In other embodiments 400 and 500, the catheters of the present invention include cuts 150 that are curved, as shown in
In one embodiment, the catheter of the present invention is a multi-lumen catheter, such as the dual-lumen catheter 600 shown in
The materials used to fabricate the catheters of the present invention are any suitable polymeric materials as are known in the art, such as thermoplastic polyurethanes, nylons, polyether block amides, ethylene vinyl acetate, silicones, polyolefin elastomers, styrenic elastomers, and polyester elastomers. The catheters are preferably manufactured by extrusion fabrication techniques, as are known in the art. The cuts provided in the catheters of the present invention may be made by any suitable cutting process, by removing sidewall material through micro-milling, radiofrequency welding, or other suitable machining technique, or by molding or extruding the catheters with the cuts in an as-manufactured configuration.
As described herein, the catheters of the present invention include sidewall portions defined by cuts that move relative to each other when the catheter is subjected to internal and/or external forces above a threshold force. As used herein, the term “threshold force” is intended to mean the force required to move at least part of the sidewall portions, as described herein, relative to each other. As such, the threshold force will differ for each catheter, and will depend upon factors such as the composition, thickness, and geometry of the catheter sidewall.
It will be apparent to those skilled in the art that various modifications and variations can be made in the structure and methodology of the present invention. Thus, it is intended that the present invention cover such modifications and variations provided that they come within the scope of the appended claims and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
3094124 | Birtwell | Jun 1963 | A |
3438375 | Ericson | Apr 1969 | A |
3978157 | Bottenbruch et al. | Aug 1976 | A |
4054139 | Crossley | Oct 1977 | A |
4142525 | Binard et al. | Mar 1979 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4423740 | Castle et al. | Jan 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4469483 | Becker et al. | Sep 1984 | A |
4483688 | Akiyama | Nov 1984 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4569673 | Tesi | Feb 1986 | A |
4592920 | Murtfeldt | Jun 1986 | A |
4603152 | Laurin et al. | Jul 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4902503 | Umemura et al. | Feb 1990 | A |
4944726 | Hilal et al. | Jul 1990 | A |
5019096 | Fox et al. | May 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5125893 | Dryden | Jun 1992 | A |
5133742 | Pinchuk | Jul 1992 | A |
5151231 | Lambert et al. | Sep 1992 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5229431 | Pinchuk | Jul 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5300048 | Drewes et al. | Apr 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405340 | Fageol et al. | Apr 1995 | A |
5472417 | Martin et al. | Dec 1995 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5542937 | Chee et al. | Aug 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5614136 | Pepin et al. | Mar 1997 | A |
5662913 | Capelli | Sep 1997 | A |
5683640 | Miller et al. | Nov 1997 | A |
5725510 | Hartmann et al. | Mar 1998 | A |
5800414 | Cazal | Sep 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5879499 | Corvi | Mar 1999 | A |
5928174 | Gibbins | Jul 1999 | A |
6033393 | Balbirz et al. | Mar 2000 | A |
6093180 | Elsberry | Jul 2000 | A |
6177522 | Brady et al. | Jan 2001 | B1 |
6197846 | Cmbe et al. | Mar 2001 | B1 |
6200338 | Solomon et al. | Mar 2001 | B1 |
6217566 | Ju et al. | Apr 2001 | B1 |
6227200 | Crump et al. | May 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6315789 | Cragg | Nov 2001 | B1 |
6355858 | Gibbins | Mar 2002 | B1 |
6368658 | Schwarz et al. | Apr 2002 | B1 |
6375637 | Campbell et al. | Apr 2002 | B1 |
6409700 | Siegel, Jr. et al. | Jun 2002 | B1 |
6442415 | Bis et al. | Aug 2002 | B1 |
6446671 | Armenia et al. | Sep 2002 | B2 |
6517520 | Chang et al. | Feb 2003 | B2 |
6530951 | Bates et al. | Mar 2003 | B1 |
6545097 | Pinchuk et al. | Apr 2003 | B2 |
6595966 | Davey et al. | Jul 2003 | B2 |
6605751 | Gibbins et al. | Aug 2003 | B1 |
6777466 | Eckstein et al. | Aug 2004 | B2 |
6819951 | Patel et al. | Nov 2004 | B2 |
6897349 | Gibbins et al. | May 2005 | B2 |
6938668 | Whicher et al. | Sep 2005 | B2 |
7179849 | Terry | Feb 2007 | B2 |
7264858 | Belliveau et al. | Sep 2007 | B2 |
7410602 | Davey et al. | Aug 2008 | B2 |
20010037065 | Graf et al. | Nov 2001 | A1 |
20020082559 | Chang et al. | Jun 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020156430 | Haarala et al. | Oct 2002 | A1 |
20030065355 | Weber | Apr 2003 | A1 |
20030203991 | Schottman et al. | Oct 2003 | A1 |
20040068241 | Fischer, Jr. | Apr 2004 | A1 |
20040068251 | Chan et al. | Apr 2004 | A1 |
20040068315 | Chandrasekaran et al. | Apr 2004 | A1 |
20040073171 | Rogers et al. | Apr 2004 | A1 |
20040076582 | DiMatteo et al. | Apr 2004 | A1 |
20040131863 | Belliveau et al. | Jul 2004 | A1 |
20040171747 | Zhong | Sep 2004 | A1 |
20040199128 | Morris et al. | Oct 2004 | A1 |
20040220534 | Martens et al. | Nov 2004 | A1 |
20040266301 | Vedula et al. | Dec 2004 | A1 |
20050010275 | Sahatjian et al. | Jan 2005 | A1 |
20050013988 | Fu et al. | Jan 2005 | A1 |
20050119724 | Phaneuf et al. | Jun 2005 | A1 |
20050131356 | Ash et al. | Jun 2005 | A1 |
20050182352 | DiMatteo et al. | Aug 2005 | A1 |
20050192546 | Grieg et al. | Sep 2005 | A1 |
20050216074 | Sahatjian et al. | Sep 2005 | A1 |
20060004325 | Hamatake et al. | Jan 2006 | A1 |
20060052757 | Fischer et al. | Mar 2006 | A1 |
20060189922 | Amarasinghe et al. | Aug 2006 | A1 |
20070299043 | Hunter et al. | Dec 2007 | A1 |
20080108975 | Appling et al. | May 2008 | A1 |
20080234659 | Cheng et al. | Sep 2008 | A1 |
20090036768 | Seehusen et al. | Feb 2009 | A1 |
20090171319 | Guo et al. | Jul 2009 | A1 |
20090171436 | Casanova et al. | Jul 2009 | A1 |
20090326560 | Lampropoulos et al. | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
20208420 | Oct 2002 | DE |
0328421 | Aug 1989 | EP |
0589577 | Mar 1994 | EP |
0987042 | Mar 2000 | EP |
2718969 | Oct 1995 | FR |
2001172848 | Jun 2001 | JP |
2001340466 | Dec 2001 | JP |
2003037632 | Feb 2003 | JP |
2006296694 | Nov 2006 | JP |
WO-9641649 | Dec 1996 | WO |
WO-9710858 | Mar 1997 | WO |
WO-9938550 | Aug 1999 | WO |
WO-9942156 | Aug 1999 | WO |
WO-0053253 | Sep 2000 | WO |
WO-0170324 | Sep 2001 | WO |
WO-2006058042 | Jun 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20110172642 A1 | Jul 2011 | US |